TB-4 (10mg)

Description

Thymosin Beta-4 (TB4)

Thymosin Beta-4 (TB4) is a naturally occurring 43-amino acid peptide found in high concentrations in nearly all human cells and tissues. It serves as the full-length precursor to TB-500 and is extensively researched for its broad regenerative, anti-inflammatory, and tissue repair properties. TB4 plays a critical role in actin sequestration, cell migration, stem cell differentiation, angiogenesis, and wound healing, making it a key subject in regenerative medicine, injury recovery, and anti-aging research.

Key Benefits

• Broad Tissue Regeneration: Supports healing across multiple tissue types including muscle, tendon, ligament, skin, and organs.
• Powerful Anti-Inflammatory Effects: Helps modulate inflammation and reduce excessive scar tissue formation.
• Promotes Angiogenesis: Stimulates new blood vessel formation to improve nutrient and oxygen delivery to damaged tissues.
• Stem Cell Activation: Enhances recruitment and differentiation of stem cells to injury sites.
• Neuroprotective and Cardioprotective Potential: Studied for benefits in brain injury, stroke, heart repair, and neurodegenerative conditions.
• Improved Healing Quality: May lead to more functional tissue repair with reduced fibrosis and adhesions.

Administration Options

• Subcutaneous (SQ) Injection: Most common route for systemic effects.
• Intramuscular (IM) Injection: Used for targeted delivery to specific injury sites.
• Intranasal: Occasionally explored for potential neurological and systemic benefits.

Potential Side Effects

• Generally Well-Tolerated: Considered to have a good safety profile in research settings.
• Mild: Temporary fatigue, lightheadedness, nausea, or headache.
• Local Reactions: Redness, itching, or swelling at injection site.
• Rare: Mild flu-like symptoms or skin reactions in sensitive individuals.

Note: Thymosin Beta-4 (TB4) is not FDA-approved and is used exclusively for research purposes.